Table 7.
The top 5 centrality of co-cited reference of NMBM of PD.
| Ranking | Cited reference | Representative author | Centrality | Journal | Publication year |
|---|---|---|---|---|---|
| 1 | Submandibular gland biopsy for the diagnosis of Parkinson disease[33] | Thomas G. Beach | 0.37 | J Neuropath Exp Neurol | 2013 |
| 2 | New clinical subtypes of Parkinson disease and their longitudinal progression: A prospective cohort comparison with other phenotypes[32] | Seyed-Mohammad Fereshtehnejad | 0.36 | JAMA Neurol | 2015 |
| 3 | Biomarkers for cognitive impairment in Parkinson disease[34] | Min Shi | 0.34 | Brain Pathol | 2010 |
| 4 | Cognitive impairment in incident, untreated Parkinson disease[35] | D. Aarsland | 0.33 | Neurology | 2009 |
| 5 | Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review[36] | Graziella Orrù | 0.33 | Neurosci Biobehav Rev | 2012 |
NMBM = neuroimaging biomarker, PD = Parkinson disease.